About the Journal

Focus and Scope

Magna Neurologica is a peer-reviewed and open access journal that focuses on promoting neurological sciences generated from basic neurosciences and clinical neurology. This journal publishes original articles, reviews, and also interesting case reports. Brief communications containing short features of medicine, latest developments in diagnostic procedures of neurology disease, treatment, or other health issues related to neurology that is important also acceptable. Letters and commentaries of our published articles are welcomed.

Subjects suitable for publication include:
• Neuroepidemology
• Neurovascular
• Neuroinfection
• Neurobehavior
• Neuroimmunology
• Neurodegenerative
• Neurootology
• Neuroophtalmology
• Neuropediatric
• Neurointervention
• Neuroradiology
• Neurorestoration
• Movement disorder
• Sleep disorder
• Pain and pain intervention
• Neuroinfection
• Neuroendocrinology
• Neurosurgery
• Neuropathology
• Neurophysiology
• Neuroanaesthesiology
• Neurooncology
• Neuropharmacology
• Neuroanatomy

Peer Review Process

1.  Magna Neurologica employs a double-blind peer-review method, namely that both reviewer's and author's (s) identities will be concealed from each other.

2. Initial screening. All submitted manuscripts will be screened by the Section Editor to determine whether the manuscript abides by the focus and scope of Magna Neurologica. Manuscripts that do not meet the basic requirements will be rejected without further review.

3. If the manuscript meets these two criteria, it is checked for plagiarism or duplicate publication with a similarity check using Turnitin before the article is subjected to a substantial review process to prevent potential title similarities with previously published articles. After confirming its result, it is dispatched to two reviewers in the field with relevant knowledge.

4. Peer-review. All manuscripts that pass the initial screening stage, will be distributed to two experts in the relevant field to undergo a double-blind peer-review.

5. First Decision. A decision on a peer-reviewed manuscript will be given once both reviewers have submitted their review reports. In the event that both reviewers have differing opinions about the manuscript, the final decision will be handed over to the Section Editor. At this stage, the author(s) will receive at least one of these decisions: accepted; revision required; or rejected.

6. Revision Stage. Manuscripts that have been recommended for revision will be returned to the submitting author. Author(s) will have up to 1 month to revise the manuscripts. The revision process will be limited to a maximum of two rounds.

7. Final Decision. If the author(s) fail to meet the revision requirements after the second round, the manuscript will be rejected. All accepted manuscripts will go through the final editing and layout process.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public, supports a greater global exchange of knowledge. Authors of articles published remain the copyright holders and grant third parties the right to use, reproduce, and share the article according to the Creative Commons Attribution 4.0 International License license agreement. 

Archiving Policy

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

Publication Frequency

Magna Neurologica publishes twice in a year, every January and July.

Article Processing Charges

Magna Neurologica is an open access international journal. This open access journal does not charge any processing or publishing fees for every article published. 

Plagiarism Policy

The manuscript that submitted into this journal will be screened for plagiarism using Turnitin. Manuscript with similarity rate more than 25% will be return immediately to the author(s).

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.